← Product Code [KXF](/submissions/HO/subpart-g%E2%80%94general-hospital-and-personal-use-miscellaneous-devices/KXF) · K013820 # FINN CHAMBER (R) (K013820) _Epitest Ltd. OY · KXF · Jan 30, 2002 · General Hospital · SESE_ **Canonical URL:** https://fda.innolitics.com/submissions/HO/subpart-g%E2%80%94general-hospital-and-personal-use-miscellaneous-devices/KXF/K013820 ## Device Facts - **Applicant:** Epitest Ltd. OY - **Product Code:** [KXF](/submissions/HO/subpart-g%E2%80%94general-hospital-and-personal-use-miscellaneous-devices/KXF.md) - **Decision Date:** Jan 30, 2002 - **Decision:** SESE - **Submission Type:** Traditional - **Regulation:** 21 CFR 880.6025 - **Device Class:** Class 1 - **Review Panel:** General Hospital ## Indications for Use Finn Chamber® is an aluminum holding device to place allergens and allergen mixes in contact with the surface of skin during allergen patch testing. This product is intended for use by or under the supervision of a physician in the testing of individuals suspected of having allergies. It is not intended for over-the-counter use. ## Device Story Finn Chamber is an aluminum holding device used during allergen patch testing. It functions as a physical container to hold allergens or allergen mixes against the patient's skin. The device is used in a clinical setting under the supervision of a physician to assist in the diagnosis of suspected allergies. It does not perform analysis or provide automated outputs; it serves as a mechanical delivery interface for patch testing materials. ## Clinical Evidence No clinical data provided; device is a mechanical holding accessory for patch testing. ## Technological Characteristics Aluminum holding device for allergen patch testing. Form factor designed for skin contact. No electronic components, software, or energy sources. ## Regulatory Identification An absorbent tipped applicator is a device intended for medical purposes that consists of an absorbent swab on a wooden, paper, or plastic stick. The device is used to apply medications to, or to take specimens from, a patient. ## Predicate Devices - IQ Chamber ([K992553](/device/K992553.md)) ## Submission Summary (Full Text) > This content was OCRed from public FDA records by [Innolitics](https://innolitics.com). If you use, quote, summarize, crawl, or train on this content, cite Innolitics at https://innolitics.com. > > Innolitics is a medical-device software consultancy. We help companies design, build, and clear FDA-regulated software and AI/ML devices, including [a 510(k)](https://innolitics.com/services/510ks/), [a De Novo](https://innolitics.com/services/regulatory/), [a SaMD](https://innolitics.com/services/end-to-end-samd/), [an AI/ML medical device](https://innolitics.com/services/medical-imaging-ai-development/), or [an FDA regulatory strategy](https://innolitics.com/services/regulatory/). {0}------------------------------------------------ Image /page/0/Picture/0 description: The image contains the logo of the U.S. Food and Drug Administration (FDA). On the left is the Department of Health & Human Services logo. To the right of that is the FDA logo, which is a blue square with the letters "FDA" in white. To the right of the blue square is the text "U.S. FOOD & DRUG ADMINISTRATION" in blue. Epitest Limited Oy c/o Clawson Bowman Vice President, Regulatory Affairs and Clinical Affairs 1330A Redwood Way Petaluma, California 94954-1169 November 1, 2024 Re: K013820 Trade/Device Name: Finn Chamber® Regulation Number: 21 CFR 880.6025 Regulation Name: Absorbent tipped applicator Regulatory Class: Class I Product Code: KXF Dear Clawson Bowman: The Food and Drug Administration (FDA) is sending this letter to notify you of an administrative change related to your previous substantial equivalence (SE) determination letter dated January 30, 2002. Specifically, FDA is updating this SE Letter because FDA has better categorized your device technology under product code KXF. Please note that the 510(k) submission was not re-reviewed. For questions regarding this letter please contact David Wolloscheck, OHT3: Office of GastroRenal, OB-Gyn, General Hospital and Urology Devices, 301-796-1480, David.Wolloscheck(@fda.hhs.gov. Sincerelv. David Wolloscheck -S David Wolloscheck, Ph.D. Assistant Director DHT3C: Division of Drug Delivery and General Hospital Devices and Human Factors OHT3: Office of GastroRenal, OB-Gyn, General Hospital and Urology Devices Office of Product Evaluation and Quality Center for Devices and Radiological Health {1}------------------------------------------------ Image /page/1/Picture/1 description: The image shows the seal of the Department of Health & Human Services (HHS) of the United States of America. The seal features the department's name encircling a symbol. The symbol consists of a stylized caduceus, which is a staff with two snakes entwined around it, representing medicine and health. #### Public Health Service Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20850 - # JAN 3 0 2002 Epitest Limited Oy C/O Mr. Clawson Bowman Vice President, Regulatory and Clinical Affairs Dow Pharmaceutical Sciences 1330A Redwood Way Petaluma, California 94954-1169 Re: K013820 Trade/Device Name: Finn Chamber ® Regulation Number: None Regulation Name: Allergen and Vaccine Delivery System Regulatory Class: Unclassified Product Code: LDH Dated: November 15, 2001 Received: November 16, 2001 Dear Mr. Bowman: We have reviewed your Section 510(k) premarket notification of intent to market the device the device We have reviewed your Secuon 510(x) profix) is substantially equivalent (for the referenced above and have determined the develop predicated predicate devices marketed in indications for use stated in the enclosure) to legally madical Device indications for use stated in the checked to to regioned date of the Medical Device interstate commerce prior to May 20, 1970, the sitived in accordance with the provisions of Amendments, or to devices that have been reclassified in accordance approval of a Amendments, or to devices that have been received to ret require approval of a premarket the Federal Food, Drug, and Cosmetic Act (Act) that douice, subject to the general the Federal Food, Drug, and Cosinent Act (recree, market the device, subject to the general approval application (PMA). You may, therefore, market the device, subject to the approval application (FMA). Tou may, includes provisions of the Act include controls provisions of the Act. The genting of devices, good manufacturing practice, requirements for annual registration, listing of devices, good manufacturing practice, requirements for annials against misbranding and adulteration. If your device is classified (see above) into either class II (Special Controls) or class III If your device is classified (see above) into controls. Existing major regulations affecting (PMA), it may be subject to such additional voluless, Title 21, Parts 800 to 898. In your device can be found in the Code of Federal Regulations, Title Federal your device can be found in the Code of Pederal Regaring your device in the Federal Register. Please be advised that FDA's issuance of a substantial equivalence determination does not Please be advised that FDA s Issualice of a substanian oque ransplies with other requirements {2}------------------------------------------------ # Page 2 - Mr. Bowman of the Act or any Federal statutes and regulations administered by other Federal agencies. The segment of the Malantations and reguirements, including, but not limited to: re of the Act or any Federal statutes and regulations administered by out not limited to: registration You must comply with all the Act's requirements, including, but not limite of the rest comply with all the Act's requirements, including, out mor mintening practice and listing (21 CFR Part 807); labeling (21 CFR Part 801); good manufacturing practi I ca listing (21 CFR Part 807); abeling (21 CFR Part 801); good marker (21 CFR Part 820); and if requirements as set forth in the quality systems (OS) regulation (21 CFR Part and fishing (S) = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = 21 CFR 1000-1050. 21 Or Section will allow you to begin marketing your device as described in your Section. This letter will allow you to begin marketing your device as described in your device to 510(k) premarket notification. The FDA finding of substantial equivalence of your de 510(k) premarket notification. The FDA Inding of substance quarter and thus, a legally marketed predicate device results in a classification for your device and thus, a lega a legally marketed proceed to the market. permise specific advice for your device on our labeling regulation (21 CFR Part 801 CFR Partificant and Review 800 10 for in vitro diagnostic devices), please contact the If you desire specific advice for your device on our labentify regimss). please contact the and additionally 21 CFR Part 809.10 for in vitro diagnostic devices in the promoti If you asono if Office of Compliance (301) 594-4618. Additionally, for questions on the promotion and Office of Compliance and 301) 594-4618. Additionally, for questions on Office of Compliance at (301) 594-4618. Adaltonally, for quisate at (301) 594-4639. advertising of your device, please contact the Office of Compliance at (301) 594-4639. ad advertising of your device, please contact the Ontice of Complete of preference to premarket. Also, please note the regulation entitled, "Misbranding by reference to Also, please note the regulation entitled, "Misfrancing by recense on responsibilities under notification" (21CFR Part 807.97). Other general information on your responsibil notification" (21CFR Part 807.97). Other general information of Small Manufacturers, International and the Act may be obtained from the Division of Small Manufacturers, Inte the Act may be obtained from the Division of Small Manufacturers, 2001 443-6597 or at its the Act may be obtained from the Division of S00) 638-2041 or (301) 443-6597 or at i Consumer Assistance at its toll-free number (800) 030 2012 (1888) (1888) 1987 (1987) 1987) 1987 (1987) 1987) 1987 Sincerely yo A. Ulatowski Th Director Division of Dental, Infection Control and General Hospital Devices Office of Device Evaluation Center for Devices and Radiological Health {3}------------------------------------------------ Dow Pharmaceutical Sciences Kol3820 3 ### B. Statement of Indication for Use Applicant: Epitest Ltd Oy 510(k) Number: not-known 长۵۱ 38 Q 0 Device Name: Finn Chamber® Indication For Use: Finn Chamber® is an aluminum holding device to place allergens and allergen mixes and allering and and the most the tasting Finil Chambers is an face of skin during allergen patch testing. This product is intended for use by or under the supervision of a physician in the This product is intended for use by or under the super research of the not intended for over-thecounter use. Patrovo Ciccerite Division Sign-Off) Division Sign-only Infection Control, Division of Dental, Infection Control, Division General Hospital Devices 810 General Hoston Kol3820 {4}------------------------------------------------ #### K013820 510(k) Premarket Notification Finn Chamber® | C. 510(k) Summary | JAN 3 0 2002 | |----------------------|------------------------------------------------------------------------------------------| | Submitter: | Dow Pharmaceutical Sciences
1330A Redwood Way
Petaluma, CA 94954
(707) 793-2600 | | | On Behalf of:
Epitest Ltd Oy
Rannankoukku 22
FIN-04300 Tuusula, Finland | | Contact: | Clawson Bowman, J.D.
Vice President, Regulatory and Clinical Affairs | | Date: | November 15, 2001 | | Device Name: | Finn Chamber® | | Classification Name: | Allergen and Vaccine Delivery System | | Predicate Device: | IQ Chamber (K992553) (Dormer Laboratories, Inc.) | Description: Finn Chamber® is an aluminum holding device to place allergens and allergen mixes in contact with the surface of skin during allergen patch testing. This product is intended for use by or under the supervision of a physician in the testing of individuals suspected of having allergies. It is not intended for over-thecounter use. Finn Chamber® is substantially equivalent to various marketed allergen and vaccine delivery systems including IQ Chamber (K992553). --- **Source:** [https://fda.innolitics.com/submissions/HO/subpart-g%E2%80%94general-hospital-and-personal-use-miscellaneous-devices/KXF/K013820](https://fda.innolitics.com/submissions/HO/subpart-g%E2%80%94general-hospital-and-personal-use-miscellaneous-devices/KXF/K013820) **Published by [Innolitics](https://innolitics.com)** — a medical-device software consultancy. We help companies design, build, and clear FDA-regulated software and AI/ML devices. If you're preparing [a 510(k)](https://innolitics.com/services/510ks/), [a De Novo](https://innolitics.com/services/regulatory/), [a SaMD](https://innolitics.com/services/end-to-end-samd/), [an AI/ML medical device](https://innolitics.com/services/medical-imaging-ai-development/), or [an FDA regulatory strategy](https://innolitics.com/services/regulatory/), [get in touch](https://innolitics.com/contact). **Cite:** Innolitics at https://innolitics.com